In both subgroups, patients in the low-risk group had longer overall survival; in addition, ApoB and the ApoB/apoa1 ratio were risk factors for MM patients, and survival times were extended when total cholesterol and HDL-C levels found elevated [159]. Here, APOA1 is linked to Miyoshi myopathy.